Last updated on February 2018

Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide Etoposide Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)


Brief description of study

This study evaluates the efficacy and safety of Chidamide plus CHOP regimen for de novo PTCL patients.

Detailed Study Description

After enrollment, patients in this study will be given Chidamide, Cyclophosphamide, Epirubicin, Vincristine and Prednisone, and the efficacy and safety of this regimen are then evaluated.

Clinical Study Identifier: NCT03268889

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.